Intrinsic Value of S&P & Nasdaq Contact Us

Precision BioSciences, Inc. DTIL NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
56/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$19.00
+162.8%

There have been 50 recent insider transactions recorded for Precision BioSciences, Inc. (DTIL), including 20 buys and 30 sells. Total insider buying was valued at $129.14K and total insider selling at $513.32K.

Notable insiders with recent activity include Kelly John Alexander, Smith J. Jefferson, Scimeca Dario. Insider transactions can provide insights into how company leadership views the stock's valuation and future prospects.

Insider Transactions — DTIL

Date Name Role Transaction Shares Avg. Price Value Shares Owned
2026-02-18 Kelly John Alexander Chief Financial Officer Informative Sell 8,149 $3.84 $31.29K 125,883
2026-02-18 Smith J. Jefferson Chief Research Officer Informative Sell 4,925 $3.84 $18.91K 121,926
2026-02-18 Scimeca Dario General Counsel and Secretary Informative Sell 4,925 $3.84 $18.91K 56,457
2026-02-18 Amoroso Michael President and CEO Informative Sell 20,559 $3.84 $78.95K 243,392
2026-02-17 Kelly John Alexander Chief Financial Officer Option Exercise (Sell) 27,584 - - 55,166
2026-02-17 Smith J. Jefferson Chief Research Officer Option Exercise (Sell) 16,667 - - 33,333
2026-02-17 Scimeca Dario General Counsel and Secretary Option Exercise (Sell) 16,667 - - 33,333
2026-02-17 Amoroso Michael President and CEO Option Exercise (Sell) 67,797 - - 135,593
2026-01-22 Amoroso Michael President and CEO Informative Sell 34,799 $4.17 $145.11K 196,154
2026-01-21 Kelly John Alexander Chief Financial Officer Informative Sell 15,213 $4.03 $61.31K 106,448
2026-01-21 Smith J. Jefferson Chief Research Officer Informative Sell 10,200 $4.03 $41.11K 110,184
2026-01-21 Scimeca Dario General Counsel and Secretary Informative Sell 8,854 $4.03 $35.68K 44,715
2026-01-20 Kelly John Alexander Chief Financial Officer Option Exercise (Sell) 3,888 - - -
2026-01-20 Smith J. Jefferson Chief Research Officer Option Exercise (Sell) 2,500 - - -
2026-01-20 Scimeca Dario General Counsel and Secretary Option Exercise (Sell) 1,978 - - -
2026-01-20 Amoroso Michael President and CEO Option Exercise (Sell) 8,888 - - -
2025-12-16 Germano Geno J Director Informative Buy 3,000 $4.72 $14.16K 23,883
2025-12-16 Frankel Stanley Director Informative Buy 2,700 $4.70 $12.69K 19,478
2025-12-15 Brown Melinda Director Informative Buy 1,381 $4.97 $6.86K 23,346
2025-11-03 Kelly John Alexander Chief Financial Officer Informative Sell 1,303 $6.49 $8.46K 77,298
2025-11-03 Scimeca Dario General Counsel and Secretary Informative Sell 665 $6.49 $4.32K 28,258
2025-11-03 Amoroso Michael President and CEO Option Exercise (Sell) 9,444 - - -
2025-11-02 Kelly John Alexander Chief Financial Officer Option Exercise (Sell) 3,605 - - -
2025-11-02 Scimeca Dario General Counsel and Secretary Option Exercise (Sell) 1,835 - - -
2025-11-02 Amoroso Michael President and CEO Option Exercise 9,444 - - 118,984
2025-09-26 Frankel Stanley Director Informative Buy 2,700 $4.97 $13.42K 16,778
2025-09-22 Brown Melinda Director Informative Buy 1,400 $4.89 $6.85K 21,965
2025-07-03 Kelly John Alexander Chief Financial Officer Informative Sell 14,827 $4.26 $63.16K 73,485
2025-06-25 Brown Melinda Director Informative Buy 1,682 $4.14 $6.96K 20,565
2025-06-25 Buehler Kevin Director Informative Buy 5,076 $4.16 $21.12K 28,137
2025-06-03 Germano Geno J Director RSU Award 21,000 - - 21,000
2025-06-03 Brown Melinda Director RSU Award 21,000 - - 21,000
2025-06-03 Buehler Kevin Director RSU Award 21,000 - - 21,000
2025-06-03 Frankel Stanley Director RSU Award 21,000 - - 21,000
2025-06-03 Pire Shari Lisa Director RSU Award 21,000 - - 21,000
2025-06-02 Kelly John Alexander Chief Financial Officer RSU Award 82,750 - - 82,750
2025-06-02 Smith J. Jefferson Chief Research Officer RSU Award 50,000 - - 50,000
2025-06-02 Scimeca Dario General Counsel and Secretary RSU Award 50,000 - - 50,000
2025-06-02 Amoroso Michael President and CEO RSU Award 203,390 - - 203,390
2025-05-27 Germano Geno J Director Option Exercise (Sell) 9,826 - - -
2025-05-27 Brown Melinda Director Option Exercise (Sell) 9,826 - - -
2025-05-27 Buehler Kevin Director Option Exercise (Sell) 9,826 - - -
2025-05-27 Frankel Stanley Director Option Exercise (Sell) 9,826 - - -
2025-05-27 Pire Shari Lisa Director Option Exercise (Sell) 9,826 - - -
2025-03-26 Brown Melinda Director Informative Buy 1,839 $4.75 $8.74K 9,057
2025-03-26 Buehler Kevin Director Informative Buy 4,523 $4.67 $21.12K 13,235
2025-03-25 Germano Geno J Director Informative Buy 3,250 $5.30 $17.23K 11,057
2025-03-24 Amoroso Michael President and CEO Informative Sell 964 $5.56 $5.36K 109,540
2025-03-21 Amoroso Michael President and CEO Option Exercise (Sell) 3,417 - - -
2025-03-04 Smith J. Jefferson Chief Research Officer Informative Sell 154 $4.91 $756.14 87,805
Informative Buy/Sell — open market transaction (most significant) Uninformative Buy — award, option exercise, conversion Uninformative Sell — tax withholding, award vest sale Neutral — gift, trust, expiry
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message